Gaining More Predictive Results in Anti-Cancer Drug Discovery
In this webinar, an expert panel of speakers introduces the EnSight® multimode microplate reader and demonstrates how the combination of well-imaging and detection technologies can produce more reliable readouts and generate more predictive data earlier in the drug discovery process. Guest speaker, Dr. Philip Gribbon (European ScreeningPort, Hamburg), discusses the use of the EnSight system in anti-cancer drug discovery for testing cell viability and proliferation in phenotypic readouts.
Dr. Gribbon presents results comparing the use of digital phase-contrast imaging and ATP detection for routine profiling of four cancer cell lines against a panel of standard cytotoxic and anti-cancer compounds.
In this webinar, you will learn:
- How the EnSight system can help you generate more predictive data earlier in the drug discovery process.
- How to improve your data quality and reduce costs in cell-based assays.
- How the EnSight system’s imaging capabilities make it an ideal instrument for use in anti-cancer drug discovery.